tiprankstipranks
Knight Therapeutics Announces Q1 Growth and Expansion
PremiumCompany AnnouncementsKnight Therapeutics Announces Q1 Growth and Expansion
2M ago
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
PremiumPress Releases
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America
2M ago
Knight Therapeutics Shareholders Back Directors and Auditors
PremiumCompany Announcements
Knight Therapeutics Shareholders Back Directors and Auditors
2M ago
Knight Therapeutics resumed with a Buy at Canaccord
PremiumThe FlyKnight Therapeutics resumed with a Buy at Canaccord
3M ago
Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
PremiumPress Releases
Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
3M ago
Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity
PremiumPress Releases
Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity
4M ago
KHTRF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsKHTRF Upcoming Earnings Report: What to Expect?
4M ago
Notice of Knight Therapeutics’ Fourth Quarter and Year End 2023 Results Conference Call
PremiumPress Releases
Notice of Knight Therapeutics’ Fourth Quarter and Year End 2023 Results Conference Call
4M ago
Knight Therapeutics price target raised to C$7.50 from C$7 at Raymond James
PremiumThe Fly
Knight Therapeutics price target raised to C$7.50 from C$7 at Raymond James
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100